Track topics on Twitter Track topics that are important to you
The Dutch pharmaceutical company Pharvaris has raked in €60M in a Series B round to fund the clinical development of the first oral treatment for hereditary angioedema, a condition that causes swelling in the limbs and airways. The Series B round will fuel the clinical progress of Pharvaris’ oral small molecule treatment for hereditary angioedema, […]
The post Dutch Company Raises €60M to Treat Inherited Inflammatory Disease appeared first on Labiotech.eu.
Original Article: Dutch Company Raises €60M to Treat Inherited Inflammatory DiseaseNEXT ARTICLE